Tag: Howard Shelanski
Firms act on Hengrui-GSK USD12.5bn drug development deal
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
Trio acts on Nippon Paint’s USD2.3bn chemical deal
Davis Polk, Gibson Dunn, and Katzke & Morgenbesser advise on Nippon Paint’s $2.3B acquisition of AOC, owned by Lone Star Funds
Trio acts on Rio Tinto’s USD6.7bn lithium acquisition
Rio Tinto is acquiring Arcadium Lithium for $6.7 billion, pending regulatory approval
LATEST ON LAW.ASIA
MOST READ ON LAW.ASIA
In the spotlight
Three INTA board members highlight AI branding, deepfakes and Asian enforcement reshaping trademark ownership, liability and protection
Vietnam Law Firm Awards
Asia Business Law Journal reveals the country’s top law firms
